Reliability of televisits for patients with mild relapsing-remitting multiple sclerosis in the COVID-19 era.

Background: Evidence of the cost-effectiveness of telemedicine (TM) for the management of Multiple Sclerosis (MS) has been provided recently. However, some doubts persist about the accuracy of neurological examinations performed remotely.

Objectives: This study investigated the reliability of neurological evaluations performed through TM in mild MS patients as compared with standard in-person visits.